A Novel Osteogenic Activity of Suberoylanilide Hydroxamic Acid is Synergized by BMP-2

BACKGROUND: Many histone deacetylase (HDAC) inhibitors are well recognized as potential anti-cancer drugs. Inhibition of HDACs induces temporal transcription or epigenetic control, thus regulating many different biological responses. Here, we investigated the osteogenic effect of the HDAC inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Zang Hee, Kim, Hyun-Jung, Ryoo, Hyun Mo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466445/
https://www.ncbi.nlm.nih.gov/pubmed/26082914
http://dx.doi.org/10.11005/jbm.2015.22.2.51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466445/
https://www.ncbi.nlm.nih.gov/pubmed/26082914
http://dx.doi.org/10.11005/jbm.2015.22.2.51

Ejemplares similares